These data strongly suggest that CTDSP2 participates in FOXO-induced activation of Ras and PKB/Akt signalling, which is thought an important mechanism for energy homoeostasis and a major drawback for the use of PI3K–PKB/Akt inhibitors in cancer. This evidence concerns the gene CTDSP2 and cancer.